| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/04/1994 | EP0595715A1 Activated carbon as antinephrotic syndrome agent |
| 05/04/1994 | EP0595610A1 Benzo-fused lactams |
| 05/03/1994 | US5308866 Treatment of melatonin related disorders, sleep disorders, psychological disorders |
| 05/03/1994 | US5308852 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | US5308850 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 05/03/1994 | CA1329197C 1,7-substituted heptyne-2-ones |
| 05/03/1994 | CA1329126C Compounds having anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynecological disorders |
| 04/30/1994 | CA2108436A1 Antinephrotic syndrome agent |
| 04/29/1994 | CA2107443A1 Benzo-fused lactams |
| 04/28/1994 | WO1994009025A1 Gestagenically active 19,11-bridged 4-estrenes |
| 04/28/1994 | WO1994008966A1 Quinolone and acridinone derivatives for the treatment of urinary incontinence |
| 04/28/1994 | WO1994008613A2 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 04/28/1994 | WO1994008574A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2146988A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2146962A1 Gestagenically active 19,11-bridged 4-estrenes |
| 04/28/1994 | CA2146666A1 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 04/27/1994 | EP0594507A1 Use of modafinil for the treatment of urinary and fecal incontinence |
| 04/27/1994 | EP0594484A1 2-Aminopyrimidin-4-carboxamide derivatives, their preparation and their use in therapy |
| 04/27/1994 | CN1085897A Angiotension II antagonists |
| 04/27/1994 | CN1024345C Process for preparing cycloalkanylpyrrole |
| 04/24/1994 | CA2108593A1 Use of modafinil for the manufacture of a medicinal product for the treatment of urinary and fecal incontinence |
| 04/20/1994 | CN1085562A 7beta-substituted-4-aza-5alpha-cholestan-ones as 5-alpha-reductase inhibitors |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/20/1994 | CN1085543A Pharmacologically active alpha-Ûtertiary-aminomethylÙ-benzenemethanol derivatives |
| 04/20/1994 | CN1024279C 17beta-(cyclopropyloxy) and rost-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors |
| 04/19/1994 | US5304552 Renin inhibitors |
| 04/19/1994 | US5304464 Protein complex enhancing sperm motility |
| 04/14/1994 | WO1994007496A1 Tocolytic oxytocin receptor antagonists |
| 04/14/1994 | WO1994007476A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 04/14/1994 | CA2146545A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 04/14/1994 | CA2143117A1 Tocolytic oxytocin receptor antagonists |
| 04/13/1994 | EP0592367A2 Phosphono/biaryl substituted dipeptide derivatives |
| 04/13/1994 | EP0591891A2 Benzimidazole derivatives as Angiotensin II antagonists |
| 04/13/1994 | EP0591710A1 Injection solutions containing mesna |
| 04/13/1994 | EP0591584A1 N-Alkyl-3-phenyl-3-(2-halo-substituted phenoxy)Propylamines as norepinephrine uptake inhibitors |
| 04/12/1994 | US5302621 Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use |
| 04/07/1994 | CA2107604A1 Benzimidazole, pharmaceutical compositions containing these compounds and processes for preparing them |
| 04/06/1994 | EP0591057A1 Arylalkyl(thio)amides with melatonine receptor selectivity and process for their preparation |
| 04/06/1994 | EP0590971A1 6-Heterocyclyl-4-amino-1,3,4,5-tetrahydrobenz CD indoles for treating motion sickness and vomiting |
| 04/06/1994 | EP0590789A1 Excitatory amino acid receptor antagonists |
| 04/06/1994 | CN1084849A Dual action inhibitors |
| 04/05/1994 | US5300513 Vasopressin antagonists; vasodilators, hypotensive agents, water diuretics, and platelet agglutination inhibitors |
| 04/05/1994 | US5300504 Increasing renal fluid flow |
| 04/05/1994 | US5300294 Administering a steroid 5-a-reductase inhibiting compound |
| 03/31/1994 | WO1994006761A1 Benzenealkanoic acids for cardiovascular diseases |
| 03/31/1994 | WO1994006461A1 Method of prophylaxis of acute renal failure |
| 03/31/1994 | WO1994006433A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 03/31/1994 | WO1994006431A1 Novel epoxide-containing compounds |
| 03/31/1994 | WO1994006423A1 Novel use of inhibitors of phosphodiestersase iv |
| 03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
| 03/31/1994 | CA2144510A1 Novel use inhibitors of phosphodiestersase iv |
| 03/31/1994 | CA2107010A1 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz¬cd|indoles for treating motion sickness and vomiting |
| 03/30/1994 | EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter |
| 03/30/1994 | EP0589336A1 Benzoylguanidines, process for their preparation and their use as antiarrhythmic agents |
| 03/30/1994 | CN1084515A Phenyl sulfonamide endothelin antagonists |
| 03/29/1994 | US5298505 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/29/1994 | US5298503 Cardiovascular |
| 03/29/1994 | US5298495 Partricin derivatives |
| 03/29/1994 | US5298492 Inhibitors of endopeptidase and treatment of cardiovascular disorders |
| 03/29/1994 | CA1328109C Hydroxybutenolide derivatives, production and use thereof |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
| 03/22/1994 | US5296490 Pharmaceutically useful pyrazolopyridines |
| 03/17/1994 | WO1994005305A1 Digitalis-like compounds |
| 03/17/1994 | WO1994005289A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 03/17/1994 | WO1994005274A1 Glycation inhibitor |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/15/1994 | US5294632 Diuretics and vasorelaxants |
| 03/15/1994 | US5294631 Substituted benzimidazoles useful as angiotension II receptor antagonists |
| 03/15/1994 | US5294620 Hypotensive agents or compounds for cardiovascular disorders |
| 03/15/1994 | CA1327746C Method of treating fibrotic disorders |
| 03/09/1994 | EP0586085A2 Veterinary method for the treatment of ketosis in livestock |
| 03/09/1994 | EP0585383A1 Chemical compounds |
| 03/09/1994 | EP0585267A1 Herpesvirus particles and vaccine |
| 03/09/1994 | CN1083473A Novel compounds |
| 03/08/1994 | US5292906 Tricyclic steroid analogs |
| 03/08/1994 | US5292753 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 03/04/1994 | CA2484248A1 Excitatory amino acid receptor antagonists |
| 03/03/1994 | WO1994004704A1 Effects of actin filaments on fibrin clot structure and lysis |
| 03/03/1994 | WO1994004536A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | WO1994004531A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 03/03/1994 | WO1994004518A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | WO1994004503A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | WO1994004495A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 03/03/1994 | WO1993023035A3 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
| 03/03/1994 | CA2138521A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | CA2138518A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | CA2136842A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0585027A1 Use of fatty acids for treating abnormal tissue calcification |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584290A1 Endothelin antagonists |
| 03/02/1994 | EP0584159A1 Nutrient preparation. |
| 03/02/1994 | CN1083070A Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
| 03/01/1994 | CA1327359C Prostaglandin el derivatives as pharmacologically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration |
| 02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/23/1994 | EP0583421A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |